Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share Regulatory News

Pin to quick picksAstrazeneca Regulatory News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,830.00
Bid: 10,828.00
Ask: 10,832.00
Change: -84.00 (-0.77%)
Spread: 4.00 (0.037%)
Open: 10,914.00
High: 10,934.00
Low: 10,824.00
Prev. Close: 10,914.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

161718192021222324
Date   Source Headline
13th May 20153:00 pmRNSHolding(s) in Company
8th May 20152:00 pmRNSDirector/PDMR Shareholding
8th May 201511:00 amRNSDirector/PDMR Shareholding - Replacement
8th May 201510:00 amRNSDirector/PDMR Shareholding
7th May 20152:00 pmRNSDirector Declaration
1st May 20154:00 pmRNSDirector/PDMR Shareholding
1st May 201511:00 amRNSTotal Voting Rights
29th Apr 20155:30 pmRNSDirector/PDMR Shareholding
24th Apr 20155:30 pmRNSResult of AGM
24th Apr 20157:02 amRNS1st Quarter Results
24th Apr 20157:01 amRNSCollaboration with Celgene on PD-L1 in haematology
24th Apr 20157:00 amRNSAZ and Innate to collaborate in immuno-oncology
23rd Apr 20159:00 amRNSNotice of Results
17th Apr 20157:00 amRNSSelumetinib granted Orphan Drug Designation by FDA
15th Apr 20157:02 amRNSTremelimumab granted Orphan Drug Designation
15th Apr 20157:00 amRNSFDA REVIEWS SAVOR OUTCOMES STUDY RESULTS
1st Apr 201511:00 amRNSTotal Voting Rights
30th Mar 20153:00 pmRNSDirector/PDMR Shareholding
19th Mar 201511:00 amRNSNotice of AGM
19th Mar 20157:00 amRNSCOLLABORATION WITH DAIICHI SANKYO INC
18th Mar 20157:04 amRNSPOSITIVE PHASE III RESULTS FOR PT003 IN COPD
16th Mar 20157:00 amRNSBRILINTA PEGASUS-TIMI 54 STUDY
10th Mar 20156:24 pmRNSFiling of Form 20-F with SEC
10th Mar 201511:00 amRNSAnnual Financial Report
6th Mar 20157:00 amRNSASTRAZENECA REFINES ITS FINANCIAL REPORTING
4th Mar 201511:54 amRNSAZ TO PARTICIPATE IN US FDA EMDAC
3rd Mar 20157:05 amRNSAcquisition of Rights to Actavis' Portfolio
2nd Mar 20153:00 pmRNSTotal Voting Rights
17th Feb 20157:00 amRNSDirectorate Change
16th Feb 20157:00 amRNSPULMICORT RESPULES® US PATENT LITIGATION DECISION
5th Feb 20157:02 amRNSAZ to acquire Actavis' US respiratory portfolio
5th Feb 20157:00 amRNSFinal Results
4th Feb 20159:00 amRNSNotice of Results
2nd Feb 20152:00 pmRNSTotal Voting Rights
22nd Jan 20157:00 amRNSMAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA
14th Jan 20157:43 amRNSBRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT
2nd Jan 20152:00 pmRNSTotal Voting Rights
19th Dec 20145:40 pmRNSLYNPARZA APPROVED BY THE US FDA
18th Dec 20147:00 amRNSLYNPARZAT APPROVED IN THE EUROPEAN UNION
9th Dec 20147:00 amRNSMOVENTIG approved in the EU for OIC
5th Dec 20145:03 pmRNSJury verdict favours AZ in Nexium litigation
2nd Dec 20147:00 amRNSNew Drug Application for IRESSA accepted by US FDA
1st Dec 20142:00 pmRNSTotal Voting Rights
1st Dec 20142:00 pmRNSBlocklisting Interim Review
26th Nov 20147:00 amRNSPOSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY
24th Nov 20144:00 pmRNSPublication of Final Terms
24th Nov 20147:00 amRNSDUAKLIR GENUAIR APPROVED IN THE EU FOR COPD
19th Nov 20145:00 pmRNSLaunch and Pricing of a ?750m Bond
19th Nov 20149:41 amRNSStabilisation Notice
18th Nov 20147:00 amRNSAZ strategy on track to deliver growth and value
161718192021222324

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.